Clonidine Transdermal System Usp, 0.1 Mg/day Patch
Product Images NDC 52817-610

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Clonidine Transdermal System Usp, 0.1 Mg/day (NDC 52817-610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton (0.1 mg)

Carton (0.1 mg)
Packaging label for Clonidine Transdermal System USP 0.1 mg/day patch by TruPharma, LLC. The label indicates a package containing 4 systems and 4 adhesive covers for transdermal delivery of clonidine. It also includes prescription-only and usage instructions with a barcode and manufacturer address.*
FDA Label Image

Pouch (back) (0.1 mg)

Pouch (back) (0.1 mg)
Label of Clonidine Transdermal System USP, 0.2 mg/day patch pouch showing storage instructions, barcode, lot and expiry placeholders, and distribution information by TruPharma LLC, Tampa FL. The label instructs to tear here to remove patch and to remove clear backing before using.*
FDA Label Image

Pouch (front) (0.1 mg)

Pouch (front) (0.1 mg)
Label of Clonidine Transdermal System USP patch showing strength of 0.1 mg/day. The label includes usage guidance for programmed delivery of 0.1 mg clonidine per day for one week and a caution to remove the patch before MRI procedures. The labeler is TruPharma, LLC.*
FDA Label Image

Carton (0.2 mg)

Carton (0.2 mg)
Box label for Clonidine Transdermal System USP, 0.2 mg/day, a transdermal patch by TruPharma, LLC. The label states the box contains 4 systems and 4 adhesive covers, for programmed delivery of 0.2 mg clonidine per day for one week. It indicates Rx only and includes storage and MRI precaution information.*
FDA Label Image

Pouch (back) (0.2 mg)

Pouch (back) (0.2 mg)
Label of Clonidine Transdermal System USP 0.2 mg/day patch pouch showing instructions to tear to remove the patch, a barcode, lot number, expiration date fields, storage conditions (25°C with permitted excursions), and distributor information for TruPharma LLC, Tampa FL. The label notes the pouch contains one patch and instructs to remove clear backing before use.*
FDA Label Image

Pouch (front) (0.2 mg)

Pouch (front) (0.2 mg)
Label for Clonidine Transdermal System USP, 0.2 mg/day patch by TruPharma, LLC. The label states programmed delivery of 0.2 mg clonidine per day for one week. It includes a warning to remove the patch before MRI procedures and indicates Rx only status.*
FDA Label Image

Carton (0.3 mg)

Carton (0.3 mg)
Label for Clonidine Transdermal System USP 0.3 mg/day patch by TruPharma, LLC. The packaging indicates 4 systems and 4 adhesive covers, with programmed delivery of 0.3 mg clonidine per day for one week. It is labeled for transdermal use, prescription only.*
FDA Label Image

Pouch (back) (0.3 mg)

Pouch (back) (0.3 mg)
Label of Clonidine Transdermal System USP 0.2 mg/day patch pouch. The pouch contains one patch with instruction to remove the clear backing before use, lists storage conditions at 25°C (77°F) with allowed excursions, and shows distribution by TruPharma LLC, Tampa FL. A barcode and tear line are also visible on the label.*
FDA Label Image

Pouch (front) (0.3 mg)

Pouch (front) (0.3 mg)
Label of Clonidine Transdermal System USP 0.3 mg/day patch by TruPharma, LLC. The label states the programmed delivery dose and cautions to remove the patch before an MRI to avoid burns. The label includes the Rx only symbol and a code number.*
FDA Label Image

Adhesive-cover (0.1 mg)

Adhesive-cover (0.1 mg)
Two square adhesive cover labels for Clonidine Transdermal System USP, 0.2 mg/day patches. Both labels warn that the adhesive cover does not contain active medication and instruct to apply it over the patch if necessary. One label includes a note to see patient instructions for use of the adhesive cover. Both labels have dashed pink border lines.*
FDA Label Image

Adhesive Cover (0.2 mg)

Adhesive Cover (0.2 mg)
Packaging labels for adhesive covers used with Clonidine Transdermal System USP, 0.2 mg/day. The labels warn that the adhesive covers do not contain active medication and instruct to apply over the patch if necessary. One label includes directions to see patient instructions for use of the adhesive cover. Both labels are white with black text and a dashed purple border.*
FDA Label Image

Adhesive Cover (0.3 mg)

Adhesive Cover (0.3 mg)
Two adhesive cover labels for Clonidine Transdermal System USP, 0.2 mg/day, shown side by side. Both labels have a pink border and warn that the adhesive cover does not contain active medication and should be applied over the patch if necessary. One label includes an instruction to see patient instructions for use, along with code numbers at the bottom.*
FDA Label Image

Clonidine Structure (Clonidine Structure)

Clonidine Structure (Clonidine Structure)
Chemical structure diagram of clonidine, the active ingredient in Clonidine Transdermal System USP. The diagram shows the molecular structure with labeled chlorine (Cl) atoms attached to the aromatic ring and nitrogen atoms in the imidazoline ring.*
FDA Label Image

Cross-section-table (Cross Section Table)

Cross-section-table (Cross Section Table)
An illustration diagram showing the layer structure of a clonidine transdermal system patch. The labeled layers from top to bottom include: Backing, Drug Reservoir, Control Membrane, Adhesive, and Slit Release Liner.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
An instructional diagram showing application of the Clonidine Transdermal System patch. It depicts a patch placed on the skin with an adhesive cover to be applied over the patch if necessary, indicating correct placement on the upper arm or shoulder area.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
Packaging labels for Clonidine Transdermal System USP 0.2 mg/day patches, showing two separate packets. One labeled as containing the medication patch, and the other labeled as containing an adhesive cover for use if the patch becomes loose. Both packets include clear usage instructions and warnings.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
An instructional illustration showing hands removing a Clonidine Transdermal System USP patch from its protective packaging, demonstrating correct handling for application. The patch delivers 0.2 mg/day via the transdermal route.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
An instructional illustration showing hands peeling a protective backing film from a transdermal patch, likely demonstrating the preparation of the Clonidine Transdermal System USP patch for application.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
An instructional black-and-white illustration showing a hand applying a patch to the skin on the upper chest or upper arm area, demonstrating the correct placement of a transdermal system patch.*
FDA Label Image

Figure-6 (Figure 6)

Figure-6 (Figure 6)
An illustration showing a round transdermal patch next to its adhesive cover labeled with warnings not to apply the cover over the patch. This diagram is associated with the Clonidine Transdermal System USP, 0.2 mg/day, a prescription transdermal patch by TruPharma, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.